ATLANTA, June 14, 2010 /EurekAlert/ -- UCB today announced the availability of an oral solution formulation of Vimpat® (lacosamide) C-V, an antiepileptic drug (AED) for add-on treatment of ...
ATLANTA, Nov. 30, 2010 /PRNewswire/ -- New data on UCB's anti-epileptic drug (AED) Vimpat® (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking ...
BRUSSELS, BELGIUM--(MARKET WIRE)--Oct 29, 2008 -- Brussels, BELGIUM, October 29, 2008 at 7:00 CET- press release, regulated information - UCB announced today that the U.S. Food and Drug Administration ...
Atlanta – March 11, 2010 – press release – UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results